ProShare Advisors LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$257,210
+3.5%
12,553
+0.4%
0.00%0.0%
Q2 2023$248,435
+20.1%
12,503
+3.6%
0.00%0.0%
Q1 2023$206,793
-19.8%
12,072
-8.4%
0.00%0.0%
Q4 2022$257,815
+54.4%
13,174
+26.9%
0.00%0.0%
Q3 2022$167,000
+20.1%
10,381
+3.4%
0.00%
Q2 2022$139,000
-39.3%
10,043
-30.3%
0.00%
Q1 2022$229,000
-41.9%
14,408
-20.3%
0.00%
-100.0%
Q4 2021$394,000
-29.9%
18,083
-3.8%
0.00%
-50.0%
Q3 2021$562,000
-41.5%
18,804
-13.3%
0.00%
-33.3%
Q2 2021$961,000
+18.1%
21,696
+18.3%
0.00%0.0%
Q1 2021$814,000
-7.6%
18,343
+14.2%
0.00%0.0%
Q4 2020$881,000
+194.6%
16,068
+22.9%
0.00%
+200.0%
Q3 2020$299,000
+6.4%
13,070
-2.8%
0.00%
-50.0%
Q2 2020$281,000
-17.4%
13,443
-9.9%
0.00%0.0%
Q4 2019$340,000
+70.9%
14,924
-12.6%
0.00%
+100.0%
Q3 2019$199,000
-22.9%
17,070
-0.7%
0.00%
-50.0%
Q2 2019$258,000
-15.1%
17,185
-0.8%
0.00%0.0%
Q1 2019$304,000
+30.5%
17,318
+10.3%
0.00%0.0%
Q4 2018$233,00015,7040.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders